News

AddToAny

Google+ Facebook Twitter Twitter

Tech news: September

This month's top tech news stories

LifeArc

Emerging viral threats

Liverpool School of Tropical Medicine (LSTM) and charitable medical research organisation LifeArc are launching a new Translational Development Fund to help tackle infectious diseases. LifeArc will invest £2.7m to support the progression of new technologies and treatments for emerging viral threats and neglected tropical diseases. LifeArc will also join the LSTM-led Infection Innovation Consortium, making its platform to progress antibody-based treatments available to partners.

lifearc.org


Promega

DNA-encoded libraries

A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery. Researchers from Promega Corporation and WuXi AppTec generated new chemical probes from molecules identified through a DEL screen. This offers opportunities to develop novel NanoBRET Target Engagement Assays aimed at many understudied proteins, accelerating efforts in identifying new potential therapeutics.

promega.co.uk


The University of Edinburgh

Tubular tissue advance

Innovative technology that creates ultra-thin layers of human cells in tube-like structures could lead to the development of lifelike blood vessels and intestines in the lab. The technique, known as RIFLE, enables the construction of separate layers as delicate as one cell thick. Developed by experts at the University of Edinburgh, RIFLE involves injecting a small volume of liquid containing cells into a tube rotating at high speed – up to 9000 rpm. The speed of the rotation causes the cells to distribute evenly across the internal surface, with higher speeds resulting in thinner layers.

ed.ac.uk


Image credit | Promega

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top